These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 10713180

  • 1. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
    Swarbrick A, Lee CS, Sutherland RL, Musgrove EA.
    Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.
    Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL.
    J Biol Chem; 2001 Dec 14; 276(50):47675-83. PubMed ID: 11590147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 01; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 8. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar 01; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 9. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb 01; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 10. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D, Mahony D, Wills K, Lees E.
    Mol Cell Biol; 1999 Mar 01; 19(3):1775-83. PubMed ID: 10022865
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.
    Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340
    [Abstract] [Full Text] [Related]

  • 12. The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.
    Stein J, Milewski WM, Dey A.
    Islets; 2013 May 02; 5(4):156-69. PubMed ID: 23896637
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 14. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD.
    Exp Cell Res; 2000 Aug 01; 258(2):322-31. PubMed ID: 10896783
    [Abstract] [Full Text] [Related]

  • 15. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S, Hussain T, Mukhtar H.
    Arch Biochem Biophys; 2003 Feb 01; 410(1):177-85. PubMed ID: 12559991
    [Abstract] [Full Text] [Related]

  • 16. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW, Montalvo E, Massagué J.
    J Biol Chem; 1997 Oct 10; 272(41):25863-72. PubMed ID: 9325318
    [Abstract] [Full Text] [Related]

  • 17. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S, Foster JS, Bukovsky A, Diehl JA, Wimalasena J.
    Mol Carcinog; 2002 May 10; 34(1):45-58. PubMed ID: 12112322
    [Abstract] [Full Text] [Related]

  • 18. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
    Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM, Hynes NE.
    Mol Cell Biol; 2000 May 10; 20(9):3210-23. PubMed ID: 10757805
    [Abstract] [Full Text] [Related]

  • 19. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ, Chang CY, Lin JK.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329
    [Abstract] [Full Text] [Related]

  • 20. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 01; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.